文献速递生殖医学

睾酮预处理未能改善博洛尼亚标准卵巢低反应者的卵巢反应:一项随机对照试验

Testosterone does not improve ovarian response in Bologna poor responders: a randomized controlled trial (TESTOPRIM).
PubMed 文献 · Reprod Biomed Online · 2021-05-30

主要结局为获成熟卵母细胞数,三组间无显著差异(2.16、2.71、2.91,P=0.719)。结论认为睾酮预处理不能改善卵巢低反应患者的成熟卵母细胞数。

要点

  • 长效或短效睾酮预处理均未增加卵巢低反应患者的成熟卵母细胞数。
  • 睾酮组刺激启动日睾酮水平显著高于对照组,但未转化为卵巢反应改善。
  • 不推荐对博洛尼亚标准卵巢低反应患者常规使用睾酮预处理。

核心结论

  • 睾酮预处理即使延长使用时间,也不能改善卵巢低反应患者的成熟卵母细胞数。

研究设计与样本

  • 分为三组:长效睾酮组(n=17)予12.5 mg/d睾酮凝胶56天,短效睾酮组(n=16)予12.5 mg/d睾酮凝胶10天,对照组(n=未报告)无干预。

主要发现

  • 三组获成熟卵母细胞数分别为2.16、2.71和2.91(P=0.719),无显著差异。
  • 除刺激启动日睾酮水平外,其余周期参数无显著差异;睾酮组该指标高于对照组(1.67和3.03 vs 0.14,P=0.01)。
  • 泊松回归显示主要结局无显著差异:对照组vs短效组为0.925(95%CI 0.572-1.508,P=0.753),对照组vs长效组为0.873(95%CI 0.534-1.426,P=0.587)。

临床怎么用

  • 对于博洛尼亚标准定义的卵巢低反应患者,不应期望通过睾酮预处理提高获卵数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does testosterone, either in a long or short course, before IVF increase the number of mature oocytes retrieved in poor ovarian response? DESIGN: Single-centre, single-blinded, randomized controlled trial. Poor ovarian response is defined according to Bologna criteria. Sixty-three participants were included and assigned to three arms: group 1 (long testosterone [n = 17]) 12.5 mg/day testosterone gel for 56 days before ovarian stimulation; group 2 (short testosterone [n = 16]) 12.5 mg/day testosterone gel for 10 days before ovarian stimulation; and group 3 (control, no intervention). Primary outcome was number of mature oocytes retrieved. Secondary outcomes included other cycle parameters (duration of stimulation, antral follicle count, number of follicles >16 mm, total oocytes retrieved and testosterone levels). RESULTS: The number of mature oocytes retrieved did not differ between the three groups (2.16, 2.71 and 2.91, P = 0.719, groups 1, 2 and 3, respectively). No other significant differences were found in the remaining cycle parameters, except for testosterone levels at the beginning of ovarian stimulation, which were higher in both testosterone groups and relatively higher in group 2 (1.67 and 3.03, respectively versus 0.14 control group, P = 0.01). A Poisson regression model showed no significant differences for the primary outcome (group 3 versus group 2: 0.925, 95% CI 0.572 to 1.508, P = 0.753; group 3 versus group 1: 0.873, 95% CI 0.534 to 1.426, P = 0.587). CONCLUSIONS: The use of testosterone, even when applied for a prolonged period, does not improve the number of mature oocytes in poor ovarian response.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Subirá J, Algaba A, Vázquez S, et al. Testosterone does not improve ovarian response in Bologna poor responders: a randomized controlled trial (TESTOPRIM). Reprod Biomed Online. 2021. PMID: 34312088. doi:10.1016/j.rbmo.2021.05.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。